XML 27 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2019
Apr. 30, 2018
Current Assets    
Cash and cash equivalents $ 10,647 $ 9,716
Restricted cash 509 1,242
Receivables, less allowance: $361 (2019); $384 (2018) 33,259 32,660
Inventories 17,206 18,549
Prepaid expenses and other current assets 3,736 2,224
Total Current Assets 65,357 64,391
Property, Plant and Equipment, Net 16,462 14,661
Other Assets    
Deferred income taxes 1,829 1,869
Other 3,575 4,162
Total Other Assets 5,404 6,031
Total Assets 87,223 85,083
Current Liabilities    
Short-term borrowings and interest rate swaps 9,513 3,885
Current portion of long-term debt and lease obligations 1,184 1,167
Accounts payable 15,190 14,754
Employee compensation and amounts withheld 3,737 3,810
Deferred revenue 1,599 1,884
Other accrued expenses 1,510 2,116
Total Current Liabilities 32,733 27,616
Long-term debt and lease obligations 229 1,264
Accrued pension and deferred compensation costs 5,878 7,465
Other non-current liabilities 680 546
Total Liabilities 39,520 36,891
Commitments and Contingencies (Note 8)
Stockholders’ Equity    
Common stock 6,875 6,841
Additional paid-in-capital 3,133 3,006
Retained earnings 43,552 43,836
Accumulated other comprehensive loss (6,407) (5,900)
Common stock in treasury, at cost: 3 shares (53) (53)
Total Kewaunee Scientific Corporation Stockholders’ Equity 47,100 47,730
Noncontrolling Interest 603 462
Total Stockholders' Equity 47,703 48,192
Total Liabilities and Stockholders’ Equity $ 87,223 $ 85,083